Thu, September 16, 2021

Daniel Kelly, M.D. '82, a neurosurgeon and neuroscientist, will discuss the history, current state and future opportunities of psychedelic-assisted therapies for a wide spectrum of mental health, and other neuroscience disorders including depression, anxiety, addiction, and PTSD. He will provide an overview of ongoing clinical trials with psilocybin, MDMA and other psychedelics and describe current clinical trials at Pacific Treatment & Research in Psychedelics (TRIP) program.